Davenport & Co’s Zymeworks ZYME Stock Holding History

Davenport & Co’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,109	Closed	-$323K	–	748
2019 Q4	$323K	Buy	+7,109	New	+$258K	﹤0.01%	571

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Davenport & Co's ZYME Position: Q1 2020 in Review

Davenport & Co sold out of Zymeworks (ZYME) in Q1 2020, closing a stake of 7,109 shares — an estimated $323K sold.

Davenport & Co first reported a position in ZYME in Q4 2019 and held it in 1 quarter. The position peaked at $323K in Q4 2019. 116 funds tracked by Wall St. Rank hold ZYME as of Q1 2020.

Davenport & Co reported no remaining Zymeworks position as of Q1 2020 after selling out during the quarter.
Davenport & Co sold 7,109 Zymeworks shares in Q1 2020, an estimated $323K.
Davenport & Co first reported a position in Zymeworks in Q4 2019 and held it in 1 quarter.
Davenport & Co's Zymeworks position peaked at $323K in Q4 2019.
116 funds tracked by Wall St. Rank held Zymeworks as of Q1 2020.

Based on Davenport & Co's 13F filing for Q1 2020, filed 5 May 2020.